Efficacy of pharmacologic closure of patent ductus arteriosus in small-for-gestational-age extremely preterm infants

摘要

BackgroundOptimal management of the patent ductus arteriosus (PDA) in preterm infants remains controversial. Therefore, studies identifying infants who are most likely to benefit from PDA treatment are needed.